node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
ADAMTSL3 | ANAPC13 | ENSP00000286744 | ENSP00000346987 | ADAMTS-like 3 | anaphase promoting complex subunit 13; Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle. The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins- it mainly mediates the formation of ’Lys-11’-linked polyubiquitin chains and, to a lower extent, the formation of ’Lys-48’- and ’Lys-63’-linked polyubiquitin chains | 0.434 |
ADAMTSL3 | DLEU7 | ENSP00000286744 | ENSP00000420976 | ADAMTS-like 3 | deleted in lymphocytic leukemia, 7 | 0.501 |
ANAPC13 | ADAMTSL3 | ENSP00000346987 | ENSP00000286744 | anaphase promoting complex subunit 13; Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle. The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins- it mainly mediates the formation of ’Lys-11’-linked polyubiquitin chains and, to a lower extent, the formation of ’Lys-48’- and ’Lys-63’-linked polyubiquitin chains | ADAMTS-like 3 | 0.434 |
ANAPC13 | DLEU7 | ENSP00000346987 | ENSP00000420976 | anaphase promoting complex subunit 13; Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle. The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins- it mainly mediates the formation of ’Lys-11’-linked polyubiquitin chains and, to a lower extent, the formation of ’Lys-48’- and ’Lys-63’-linked polyubiquitin chains | deleted in lymphocytic leukemia, 7 | 0.424 |
BCAS3 | DLEU7 | ENSP00000375067 | ENSP00000420976 | breast carcinoma amplified sequence 3 | deleted in lymphocytic leukemia, 7 | 0.450 |
BCAS3 | UQCC | ENSP00000375067 | ENSP00000363506 | breast carcinoma amplified sequence 3 | ubiquinol-cytochrome c reductase complex chaperone | 0.440 |
CAMK2N1 | DLEU7 | ENSP00000364219 | ENSP00000420976 | calcium/calmodulin-dependent protein kinase II inhibitor 1; Potent and specific inhibitor of CaM-kinase II (CAMK2) (By similarity) | deleted in lymphocytic leukemia, 7 | 0.412 |
DLEU1 | DLEU7 | ENSP00000367422 | ENSP00000420976 | deleted in lymphocytic leukemia 1 (non-protein coding); May act as a tumor suppressor | deleted in lymphocytic leukemia, 7 | 0.418 |
DLEU7 | ADAMTSL3 | ENSP00000420976 | ENSP00000286744 | deleted in lymphocytic leukemia, 7 | ADAMTS-like 3 | 0.501 |
DLEU7 | ANAPC13 | ENSP00000420976 | ENSP00000346987 | deleted in lymphocytic leukemia, 7 | anaphase promoting complex subunit 13; Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle. The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins- it mainly mediates the formation of ’Lys-11’-linked polyubiquitin chains and, to a lower extent, the formation of ’Lys-48’- and ’Lys-63’-linked polyubiquitin chains | 0.424 |
DLEU7 | BCAS3 | ENSP00000420976 | ENSP00000375067 | deleted in lymphocytic leukemia, 7 | breast carcinoma amplified sequence 3 | 0.450 |
DLEU7 | CAMK2N1 | ENSP00000420976 | ENSP00000364219 | deleted in lymphocytic leukemia, 7 | calcium/calmodulin-dependent protein kinase II inhibitor 1; Potent and specific inhibitor of CaM-kinase II (CAMK2) (By similarity) | 0.412 |
DLEU7 | DLEU1 | ENSP00000420976 | ENSP00000367422 | deleted in lymphocytic leukemia, 7 | deleted in lymphocytic leukemia 1 (non-protein coding); May act as a tumor suppressor | 0.418 |
DLEU7 | FAM124A | ENSP00000420976 | ENSP00000280057 | deleted in lymphocytic leukemia, 7 | family with sequence similarity 124A | 0.555 |
DLEU7 | FUBP3 | ENSP00000420976 | ENSP00000318177 | deleted in lymphocytic leukemia, 7 | far upstream element (FUSE) binding protein 3; May interact with single-stranded DNA from the far- upstream element (FUSE). May activate gene expression | 0.486 |
DLEU7 | LCORL | ENSP00000420976 | ENSP00000371661 | deleted in lymphocytic leukemia, 7 | ligand dependent nuclear receptor corepressor-like; May act as transcription activator that binds DNA elements with the sequence 5’-CCCTATCGATCGATCTCTACCT-3’. May play a role in spermatogenesis (By similarity) | 0.429 |
DLEU7 | MTMR11 | ENSP00000420976 | ENSP00000391668 | deleted in lymphocytic leukemia, 7 | myotubularin related protein 11 | 0.472 |
DLEU7 | UQCC | ENSP00000420976 | ENSP00000363506 | deleted in lymphocytic leukemia, 7 | ubiquinol-cytochrome c reductase complex chaperone | 0.409 |
FAM124A | DLEU7 | ENSP00000280057 | ENSP00000420976 | family with sequence similarity 124A | deleted in lymphocytic leukemia, 7 | 0.555 |
FUBP3 | DLEU7 | ENSP00000318177 | ENSP00000420976 | far upstream element (FUSE) binding protein 3; May interact with single-stranded DNA from the far- upstream element (FUSE). May activate gene expression | deleted in lymphocytic leukemia, 7 | 0.486 |